Home › NDC Lookup › RxCUI directory › RxCUI 199690

Acitretin 25 MG Oral Capsule — RxCUI 199690

RxNorm drug concept · Semantic clinical drug
RxCUI 199690 Semantic clinical drug · SCD ● Current RxNorm concept 22 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199690
Official nameAcitretin 25 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped22
Package NDCs mapped22
Reported Medicaid activity (SDUD)3,315 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acitretin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acitretin is a type of medicine called a retinoid — it's related to vitamin A and works to help control the way your skin cells grow and shed. It's used for severe psoriasis when o...
  • What exactly is acitretin and why did my doctor prescribe it for my psoriasis?
  • Taking acitretin with your main meal makes a real difference — food helps your body absorb the medication much better. Your prescriber chose your dose based on studies where it was...
  • This is one of the most important things to understand about acitretin. It is known to cause very serious, life-threatening birth defects, and this risk doesn't go away the moment...
📖 Read our full Acitretin guide →

🕸️ Concept Web — How Acitretin 25 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acitretin 25 MG Oral Capsule RxCUI 199690

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Acitretin 16818
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acitretin Oral Capsule 370533
    • Acitretin Oral Product 1153162
    • Acitretin Pill 1153163
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acitretin 25 MG 315278

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acitretin 25 MG SCDC · 315278
  • Acitretin Oral Capsule SCDF · 370533
  • Acitretin Oral Product SCDG · 1153162
  • Acitretin Pill SCDG · 1153163

📦 FDA Products & Package NDCs

22 products · 22 package NDCs
22 package NDCs map to RxCUI 199690 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-1135-56 30 CAPSULE in 1 BOTTLE (0093-1135-56) Acitretin Teva Pharmaceuticals USA, Inc. 2013-07-19
00093-1136-56 30 CAPSULE in 1 BOTTLE (0093-1136-56) Acitretin Teva Pharmaceuticals USA, Inc. 2013-07-19
00093-1138-56 30 CAPSULE in 1 BOTTLE (0093-1138-56) Acitretin Teva Pharmaceuticals USA, Inc. 2013-07-19
00115-1750-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1750-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1751-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1751-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1752-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1752-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1753-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1753-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00378-7020-93 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-7020-93) Acitretin Mylan Pharmaceuticals Inc. 2016-03-10
00378-7023-93 30 CAPSULE in 1 BOTTLE, PLASTIC (0378-7023-93) Acitretin Mylan Pharmaceuticals Inc. 2016-03-10
42291-0086-30 30 CAPSULE in 1 BOTTLE (42291-086-30) ACITRETIN AvKARE 2017-10-11
42291-0087-30 30 CAPSULE in 1 BOTTLE (42291-087-30) ACITRETIN AvKARE 2017-10-11
42291-0088-30 30 CAPSULE in 1 BOTTLE (42291-088-30) ACITRETIN AvKARE 2017-10-11
42794-0080-08 30 CAPSULE in 1 BOTTLE (42794-080-08) ACITRETIN Sigmapharm Laboratories, LLC 2015-09-16
42794-0081-08 30 CAPSULE in 1 BOTTLE (42794-081-08) ACITRETIN Sigmapharm Laboratories, LLC 2015-09-16
42794-0083-08 30 CAPSULE in 1 BOTTLE (42794-083-08) ACITRETIN Sigmapharm Laboratories, LLC 2015-09-16
46708-0741-30 30 CAPSULE in 1 BOTTLE (46708-741-30) Acitretin Alembic Pharmaceuticals Limited 2024-08-08
46708-0742-30 30 CAPSULE in 1 BOTTLE (46708-742-30) Acitretin Alembic Pharmaceuticals Limited 2024-08-08
46708-0743-30 30 CAPSULE in 1 BOTTLE (46708-743-30) Acitretin Alembic Pharmaceuticals Limited 2024-08-08
62332-0741-30 30 CAPSULE in 1 BOTTLE (62332-741-30) Acitretin Alembic Pharmaceuticals Inc. 2024-08-08
62332-0742-30 30 CAPSULE in 1 BOTTLE (62332-742-30) Acitretin Alembic Pharmaceuticals Inc. 2024-08-08
62332-0743-30 30 CAPSULE in 1 BOTTLE (62332-743-30) Acitretin Alembic Pharmaceuticals Inc. 2024-08-08
72162-2223-03 30 CAPSULE in 1 BOTTLE (72162-2223-3) ACITRETIN Bryant Ranch Prepack 2024-01-26
Observed labelers: Amneal Pharmaceuticals of New York LLC (4) · Alembic Pharmaceuticals Inc. (3) · Alembic Pharmaceuticals Limited (3) · AvKARE (3) · Sigmapharm Laboratories, LLC (3) · Teva Pharmaceuticals USA, Inc. (3) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.